| EYPT Stock | | | USD 7.94 0.31 3.76% |
Eyepoint Pharmaceuticals financial indicator trend analysis is much more than just examining Eyepoint Pharmaceuticals latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eyepoint Pharmaceuticals is a good investment. Please check the relationship between Eyepoint Pharmaceuticals Capex To Revenue and its Cost Of Revenue accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyepoint Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Eyepoint Stock please use our
How to Invest in Eyepoint Pharmaceuticals guide.
Capex To Revenue vs Cost Of Revenue
Capex To Revenue vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Eyepoint Pharmaceuticals Capex To Revenue account and
Cost Of Revenue. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Eyepoint Pharmaceuticals' Capex To Revenue and Cost Of Revenue is 0.47. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Eyepoint Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Eyepoint Pharmaceuticals' Capex To Revenue and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Eyepoint Pharmaceuticals are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Capex To Revenue i.e., Eyepoint Pharmaceuticals' Capex To Revenue and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | 0.47 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Cost Of Revenue
Cost of Revenue is found on Eyepoint Pharmaceuticals income statement and represents the costs associated with goods and services Eyepoint Pharmaceuticals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most indicators from Eyepoint Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eyepoint Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyepoint Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Eyepoint Stock please use our
How to Invest in Eyepoint Pharmaceuticals guide.At this time, Eyepoint Pharmaceuticals'
Selling General Administrative is comparatively stable compared to the past year.
Tax Provision is likely to gain to about 87.2
K in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 137.3
M in 2024.
Eyepoint Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Eyepoint Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Eyepoint Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Eyepoint Stock Analysis
When running Eyepoint Pharmaceuticals' price analysis, check to
measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.